Your session is about to expire
← Back to Search
This trial is testing a new way to help young adults who have survived cancer manage their symptoms and improve their quality of life.
- Germ Cell Tumors
- Breast Cancer
- Young Adults
- Blood Cancers
- Psychological Distress
- Endocrine Cancer
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
- You were diagnosed with cancer when you were a young adult.You are unable to walk or move around on your own.You are unable to walk or move around on your own.You were diagnosed with cancer when you were a young adult.You were diagnosed with cancer between the ages of 18 and 39.You are unable to walk.You have a serious mental illness like schizophrenia.You have a mental health condition that is not being treated or controlled, such as bipolar disorder.You have a serious mental illness like schizophrenia.You will be taking care of young adults who have had cancer and are now receiving treatment at the Duke Cancer Institute.You underwent a complex treatment involving multiple therapies to cure an illness within the past five years.You have finished a comprehensive treatment involving multiple modes of therapy in the past 5 years.You have been diagnosed with blood, breast, stomach, intestinal, thyroid or testicular cancers, or melanoma.You have been diagnosed with certain types of cancers such as blood, breast, stomach, hormone-related, skin, or germ cell tumors.You have a mental health condition like bipolar disorder that is not being treated or managed well.You have a severe mental illness like schizophrenia.You have a mental illness that is not being treated or controlled, such as bipolar disorder.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
- Group 1: Waitlist Control
- Group 2: Behavioral Symptom Management for Young Adult Cancer Survivors
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
Is participation in the trial open to adults over 20 years of age?
"According to the criteria outlined by this trial, only participants between 18 and 39 years of age are eligible. There are 362 studies available for those below the legal age and 3144 geared towards seniors above 65."
Who fulfills the eligibility qualifications for this research trial?
"This clinical trial is accepting 120 young adults, aged between 18 and 39 years old with active malignancies. To be eligible they must qualify as Young Adult Cancer Survivors Participating in Intervention Development Interviews; have hematologic, breast, gastrointestinal, endocrine cancer or melanomat Cancer Survivors Participating in Intervention Development Interviews; have hematologic, breast, gastrointestinal, endocrine cancer or melanoma/germ cell tumors diagnosed during their youth; possess medical records from the Duke Cancer Institute to prove curative treatment involving multimodal therapy within the last five years; demonstrate fluency in English language speaking & reading abilities and agree to provide informed consent."
How many participants have been accepted for participation in this trial?
"Affirmative. Clinicaltrials.gov's data suggests that this medical research, which was first posted on January 22nd 2020, is actively searching for subjects. In total, 120 participants need to be sourced from one centre."
What are the aims of this clinical experiment?
"The primary outcome of this trial, tracked for up to 12 months after completion of the intervention, is patient satisfaction as measured by the SSTS-R. Secondary outcomes encompass group cohesion through the Group Therapy Experiences Scale (17 items rated from 1 ‘strongly agree’ to 5 ‘strongly disagree’), a decrease in social isolation with PROMIS Social Isolation Scale (6 questions ranging from 1 'never' to 5 'always'), and an increase in self-efficacy via The Self-Efficacy for Managing Chronic Disease Scale (6 ratings between 1 'not at all confident' to 10 '"
Is this research trial currently accepting participants?
"Affirmative. The clinicaltrials.gov database reveals that this experiment is currently recruiting patients, having been first posted on January 22nd of 2020 and last updated on August 2nd 2022. 120 participants are being sought from a single site."
Share this study with friends